Arkuda Therapeutics Announces Option and Asset Purchase Agreement
07 Feb 2024 //
PR NEWSWIRE
Arkuda to Present Update on ARKD-104, First-in-Class Oral Candidate for FTD-GRN
18 Jul 2023 //
PR NEWSWIRE
Arkuda Strengthens Management Team to Support Translation to the Clinic
04 Apr 2023 //
PR NEWSWIRE
Lilly, Pfizer-backed Arkuda bags $64M to test drug in dementia
10 Feb 2022 //
FIERCEBIOTECH